TheJobsMapAbout K2B Therapeutics
K2B Therapeutics is developing protein-drug/siRNA conjugates with the potential for tumor-agnostic treatment of cancer. Our team believes that K2B's conjugates will revolutionize cancer therapeutics to address significant unmet need. The foundational technology was developed at KIST (Korea Institute of Science and Technology).
- Employees
- 1 to 10
- Headquarters
- United States
Leadership
The top of K2B Therapeutics's org chart, with how many people report into each leader.
SC
Saeho Chong
Chief Executive Officer
Jobs at K2B Therapeutics
No open positions right now. Explore more companies on TheJobsMap.